SPY303.78+0.81 0.27%
DIA253.97-0.38 -0.15%
IXIC9,470.47+101.48 1.08%

NovaBay Pharmaceuticals Q1 EPS $(0.060) Beats $(0.070) Estimate, Sales $1.900M Miss $2.090M Estimate

NovaBay Pharmaceuticals (AMEX:NBY) reported quarterly losses of $(0.060) per share which beat the analyst consensus estimate of $(0.070) by 14.29 percent. This is a 78.57 percent increase over losses of $(0.280) per

Benzinga · 05/07/2020 21:00

NovaBay Pharmaceuticals (AMEX:NBY) reported quarterly losses of $(0.060) per share which beat the analyst consensus estimate of $(0.070) by 14.29 percent. This is a 78.57 percent increase over losses of $(0.280) per share from the same period last year. The company reported quarterly sales of $1.900 million which missed the analyst consensus estimate of $2.090 million by 9.09 percent. This is a 27.43 percent increase over sales of $1.491 million the same period last year.